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Abstract 
Nucleotide-binding domain and leucine-rich repeat containing proteins (NLRs) contribute 
essentially to innate immune responses. Many members of the NLR family off pattern 
recognition receptors have been intensively studied, whereas other members of this protein 
family remain poorly characterised. NLRP10 has been shown to contribute to cell-
autonomous responses against invasive bacteria mediated by NOD1 and been proposed to 
negatively regulate inflammasome function. However, little is known about the role of 
NLRP10 in signalling pathways downstream of other pattern recognition receptors. In this 
study, we aimed to analyse the function of NLRP10 in vitro and in vivo. 
In human cell lines we observed an increase in NLRP10 protein levels after stimulation with 
the TLR3 agonist poly(I:C) or infection with Sendai virus. This finding was substantiated by 
increased mRNA expression of NLRP10 in in murine embryonic fibroblasts (MEFs) after 
stimulation with poly(I:C). Analysis of cytokine secretion after TLR3 activation or infection 
with Sendai virus in MEFs revealed enhanced secretion of the cytokines CXCL1 and CCL5 in 
murine Nlrp10 knock-out cells compared to control fibroblasts. These observations indicate a 
possible a role for NLRP10 in the negative regulation of inflammatory responses downstream 
of TLR3 and RIG-I. 
As NLRP10 has been proposed to be crucially involved in the migration of dendritic cells 
(DCs) we asked if NLRP10 might also influence the migration of non-myeloid cells. In vitro 
migration assays showed normal migration in human HeLa and HaCaT cells after siRNA-
mediated knock-down of NLRP10 expression. Furthermore, Nlrp10-/- murine embryonic 
fibroblasts showed no defect in migration compared to control cells, arguing against a 
contribution of NLRP10 to the migration of the cell types analysed. 
 
The main part of this study investigated the role of NLRP10 in inflammatory responses of the 
skin using two novel Nlrp10 knock-out mouse strains. NLRP10 is highly expressed in skin 
and has been genetically linked to susceptibility for atopic dermatitis. We therefore 
concentrated our efforts on the analysis of NLRP10 in skin inflammatory disease models. 
Using the Cre-lox system, full-body as well as keratinocyte-specific Nlrp10 knock-out mice 
(Nlrp10-/- and Nlrp10K14-KO, respectively) were generated. Both Nlrp10 knock-out strains 
appeared phenotypically normal and both epidermal tissue repair and irritant contact 
dermatitis responses were not affected in Nlrp10-/- mice. In contrast, Nlrp10-/- mice showed 
significantly reduced inflammation compared to control animals in a T cell-driven contact 
hypersensitivity (CHS) model induced by 1-fluoro-2,4-dinitrobenzene 
(dinitrofluorobenzene/DNFB). Microscopic analysis revealed significantly reduced numbers of 
CD4+ and CD8+ T cell infiltrates in animals lacking NLRP10 expression. This was 
accompanied by a trend towards lower CXCL1 and TNF- mRNA levels in the inflamed 
tissue, as well as increased induction of CCL5 mRNA expression. Interestingly, epidermis-
specific deletion of Nlrp10 was sufficient to account for this phenotype, although T cell 
recruitment seemed to be unaltered in animals lacking NLRP10 expression in keratinocytes. 
Reduced infiltration of neutrophils as well as degranulation of mast cells was observed upon 
elicitation of CHS in ears of both mouse strains. This might also contribute to the reduced 
inflammation during CHS in those animals. 
Taken together, these findings provide evidence that NLRP10 contributes to T cell-mediated 
inflammatory responses in the skin and highlight a novel physiological role of NLRP10 in 
epidermal keratinocytes. 
 
